Chronic Disease Management System

描述（由申请人提供）：我们的STTR第二阶段提案旨在开发和测试Cielo New Vision，这是我们第一阶段工作的结果，是可扩展的商业健康信息系统。卫生信息技术（HIT）一直处于国家政策考虑的最前沿，因为我们已经完成了第一阶段的工作，第二阶段STTR的建议受到我们第一阶段调查结果和当前卫生政策背景的影响。我们坚信，现在是启动第二阶段的最佳时机。《美国复苏和再投资法》（ARRA）载有鼓励医疗保健提供者促进采用HIT的规定。一个系统，响应我们的第一阶段的调查结果，并允许提供者有资格获得ARRA的激励措施，将带来一个产品推向市场，将满足许多初级保健提供者的需求。我们的第一阶段工作坚定地表明，虽然Cielo Clinic存在重大缺陷，限制了其广泛使用，但其数据原则允许记录和跟踪从最早症状表达到诊断和纵向治疗的护理元素，非常适合建立一流的，有针对性的初级保健，健康信息解决方案。建立在这种数据模型上的EHR-M或临床群件解决方案允许随着时间的推移在患者内以及通过问题或诊断在患者之间进行数据跟踪和显示。Cielo New Vision将在其核心提供一个基于护理的数据结构集，其中包含插入以提供特定功能的组件。实践可以使用任何或所有插件的核心数据库，并连接到他们现有的系统。在第二阶段的提案中，我们将根据以下目标开发和测试Cielo New Vision：1.从临床医生、办公室工作人员和患者那里收集关于纸质原型的反馈，包括当前和潜在用户。2.开发拟议系统的工作原型。3.可用性测试和完善工作原型与选定的临床医生和工作人员从当前和未来的做法和病人4。进行一项前瞻性试验，比较Cielo New Vision和EHR实践的关键成果：提供循证服务，满足ARRA有意义使用标准和PCMH标准。在第二阶段完成后，我们将提供一个初级保健目标套件，旨在捕捉和报告全面的护理和病人的需求随着时间的推移。该套件在满足已知和预期标准的同时，还将允许现有系统的实践插入其现有技术，使用我们的创新数据模型利用他们的投资。在实践中，使用我们的系统的患者将能够跟踪他们的护理和需求，从症状的早期表现到诊断和治疗。 公共卫生相关性：在第二阶段完成后，我们将提供一个初级保健目标套件，旨在捕捉和报告全面的护理和病人的需求随着时间的推移。该套件在满足已知和预期标准的同时，还将允许现有系统的实践插入其现有技术，使用我们的创新数据模型利用他们的投资。在实践中，使用我们的系统的患者将能够跟踪他们的护理和需求，从症状的早期表现到诊断和治疗。

DESCRIPTION (provided by applicant): Our STTR Phase II proposal is designed to develop and test Cielo New Vision, the scalable, commercial health information system envisioned as a result of our Phase I work. Health Information Technology (HIT) has been at the forefront of the nation's policy considerations as we have been completing our Phase I work and this proposal for a Phase II STTR is influenced by both our Phase I findings and the current health policy context. We firmly believe there could be no better time to be launching our Phase II. The American Recovery and Reinvestment Act (ARRA) contains provisions for incentives to medical care providers to foster HIT adoption. A system that responds to our Phase I findings and allows providers to qualify for ARRA incentives, will bring a product to market that will meet the needs of many primary care providers. Our Phase I work firmly establishes that while Cielo Clinic has significant deficiencies limiting its broad use, its data principles which permit recording and tracking of care elements from earliest expression of symptoms through diagnosis and longitudinal treatment are admirably suited to building a first rate, primary care targeted, health information solution. An EHR-M or clinical groupware solution built on such a data model permits data tracking and display within patients over time and across patients by problem or diagnosis. Cielo New Vision will deliver at its core an episode of care based data structure with components that plug in to deliver specific functions. Practices may utilize the core database with any or all of the plug-ins and connect to their existing systems. In this Phase II proposal we will develop and test Cielo New Vision according to the following aims: 1. Elicit feedback from clinicians, office staff and patients on the paper prototype, both from current and prospective users. 2. Develop a working prototype of the proposed system. 3. Usability test and refine the working prototype with selected clinicians and staff from current and prospective practices and patients 4. Conduct a prospective trial comparing Cielo New Vision and EHR practices on key outcomes: delivery of evidence-based services, satisfaction of ARRA meaningful use standards and satisfaction of PCMH standards. At the completion of Phase II we will deliver a primary care targeted suite designed to capture and report comprehensive care and patient needs over time. This suite while addressing known and anticipated standards, will also permit practices with existing systems to plug in their existing technologies, leveraging their investments using our innovative data model. Patients in practices using our system will be able to track their care and needs from the early expression of symptoms through diagnosis and treatment over time. PUBLIC HEALTH RELEVANCE: At the completion of Phase II we will deliver a primary care targeted suite designed to capture and report comprehensive care and patient needs over time. This suite while addressing known and anticipated standards, will also permit practices with existing systems to plug in their existing technologies, leveraging their investments using our innovative data model. Patients in practices using our system will be able to track their care and needs from the early expression of symptoms through diagnosis and treatment over time.